MetLife Q1 2026 Earnings Strong EPS Beat Highlights Resilient Underwriting DNOW Q1 2026 Earnings Significant EPS Miss Amid Challenging Environment ASST Q1 2026 Earnings EPS Misses Estimates by Wide Margin Amid PreRevenue Phase TAYD Q1 2026 Earnings EPS Slightly Above Estimates Amid Strong Operational Performance Perspective Therapeutics Inc CATX Q1 2026 Earnings EPS Beat by 17 as PreRevenue Biotech Advances Radiopharmaceutical Pipeline BGS Q1 2026 Earnings EPS Surpasses Estimates by 457 as Cost Discipline Supports Bottom Line